Please assess the completion status of the following clinical trial:

Trial Title: Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Presence of risk factors for venous thromboembolism~* Any parity~* Mode of delivery:vaginal, Emergency and Elective Caesarean section~* No any contraindications for Heparin~Exclusion Criteria:~* Active antenatal or postpartum vaginal bleeding.~* Placenta previa~* Thrombocytopenia~* Sever renal or liver diseases~* Uncontrolled sever hypertension~* Any patient who is already on Heparin during pregnancy

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 48 Years
- Healthy Volunteers: f

Study Arms:
- Bemiparin (Type: ACTIVE_COMPARATOR): A new second generation Low Molecular Weight Heparin
- Enoxaparin (Type: ACTIVE_COMPARATOR): A well known Low Molecular Weight Heparin
- control group (Type: NO_INTERVENTION): Risky group patients for VTE, but they will not receive any thromboprophylactic drug.

Based on this trial design, predict the completion outcome and termination type (if applicable).